The prognostic significance of multiple station N2 in patients with surgically resected stage IIIA N2 non-small cell lung cancer
- PMID: 18756045
- PMCID: PMC2526397
- DOI: 10.3346/jkms.2008.23.4.604
The prognostic significance of multiple station N2 in patients with surgically resected stage IIIA N2 non-small cell lung cancer
Abstract
Mediastinal (N2) lymph node involvement is heterogeneous with huge variation in the extent and grouped together under stage IIIA. However, they showed a different survival even in the same stage. We tried to determine the prognostic implication of the multiple station N2 lymph node metastasis in stage IIIA N2 non-small cell lung cancer (NSCLC). The survival of stage IIIA N2 was analyzed according to the number of N2 station and their survival was compared with that of stage IIIB. In stage IIIA N2 NSCLC, multivariate analysis indicated that multiple station N2 was one of the independent prognostic factors for poor survival. The 5-yr survival of multiple station N2 IIIA (20.4%) was lower than that of single station N2 IIIA (33.8%) significantly (p=0.016). but when it was compared with that of stage IIIB (15.5%), there was no difference. Therefore, we suggest that multiple station N2 should be considered similar to stage IIIB disease with regard to predicting survival and accordingly should receive a new position in the TNM staging system.
Figures
Similar articles
-
[Survival Analysis of 121 Stage N2-IIIa Non-small Cell Lung Cancer Patients Treated with Surgery].Zhongguo Fei Ai Za Zhi. 2015 Aug;18(8):505-11. doi: 10.3779/j.issn.1009-3419.2015.08.06. Zhongguo Fei Ai Za Zhi. 2015. PMID: 26302348 Free PMC article. Chinese.
-
Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.Eur J Cardiothorac Surg. 2014 Jul;46(1):86-91. doi: 10.1093/ejcts/ezt550. Epub 2013 Dec 8. Eur J Cardiothorac Surg. 2014. PMID: 24321998
-
[Correlation between Lymph Node Ratio and Clinicopathological Features and Prognosis of IIIa-N2 Non-small Cell Lung Cancer].Zhongguo Fei Ai Za Zhi. 2019 Nov 20;22(11):702-708. doi: 10.3779/j.issn.1009-3419.2019.11.04. Zhongguo Fei Ai Za Zhi. 2019. PMID: 31771739 Free PMC article. Chinese.
-
[Clinical analysis of skip N2 metastases in stage IIIA non-small cell lung cancer].Ai Zheng. 2009 Jul;28(7):725-9. doi: 10.5732/cjc.008.10849. Ai Zheng. 2009. PMID: 19624899 Chinese.
-
Evidence reviews for the clinical and cost effectiveness of treatment regimen for the treatment of operable Stage IIIA-N2 NSCLC: Lung cancer: diagnosis and management: Evidence review C.London: National Institute for Health and Care Excellence (NICE); 2019 Mar. London: National Institute for Health and Care Excellence (NICE); 2019 Mar. PMID: 32614560 Free Books & Documents. Review.
Cited by
-
Diagnosis and management of patients with stage III non‑small cell lung cancer: A joint statement by the Lebanese Society of Medical Oncology and the Lebanese Pulmonary Society (Review).Oncol Lett. 2023 Feb 6;25(3):113. doi: 10.3892/ol.2023.13699. eCollection 2023 Mar. Oncol Lett. 2023. PMID: 36844621 Free PMC article. Review.
-
Prediction of lymph node status in completely resected IIIa/N2 small cell lung cancer: importance of subcarinal station metastases.J Cardiothorac Surg. 2019 Mar 29;14(1):63. doi: 10.1186/s13019-019-0886-y. J Cardiothorac Surg. 2019. PMID: 30925891 Free PMC article.
-
Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables.Ther Adv Med Oncol. 2011 May;3(3):127-38. doi: 10.1177/1758834011401951. Ther Adv Med Oncol. 2011. PMID: 21904576 Free PMC article.
-
Prognostic Factor and Clinical Outcome in Stage III Non-Small Cell Lung Cancer: A Study Based on Real-World Clinical Data in the Korean Population.Cancer Res Treat. 2021 Oct;53(4):1033-1041. doi: 10.4143/crt.2020.1350. Epub 2021 Feb 16. Cancer Res Treat. 2021. PMID: 33592139 Free PMC article.
-
Prognostic Factors of IIIAN2 Non-Small-Cell Lung Cancer after Complete Resection: A Systemic Review and Meta-analysis.Comput Math Methods Med. 2021 Dec 13;2021:1068090. doi: 10.1155/2021/1068090. eCollection 2021. Comput Math Methods Med. 2021. Retraction in: Comput Math Methods Med. 2023 Dec 6;2023:9865819. doi: 10.1155/2023/9865819. PMID: 34938347 Free PMC article. Retracted.
References
-
- Naruke T, Tsuchiya R, Kondo H, Asamura H. Prognosis and survival after resection for bronchogenic carcinoma based on the 1997 TNM-staging classification: the Japanese experience. Ann Thorac Surg. 2001;71:1759–1764. - PubMed
-
- Keller SM, Adak S, Wagner H, Johnson DH. Mediastinal lymph node dissection improves survival in patients with stage II and IIIA non-small cell lung cancer. Eastern Cooperative Oncology Group. Ann Thorac Surg. 2000;70:358–366. - PubMed
-
- Grunenwald D, Le Chevalier T. Re: Stage IIIA category of non-small cell lung cancer: a new proposal. J Natl Cancer Inst. 1997;89:88–89. - PubMed
-
- Pearson FG, Delarue NC, Ilves R, Todd TR, Cooper JD. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung. J Thorac Cardiovasc Surg. 1982;83:1–11. - PubMed
-
- Andre F, Grunenwald D, Pignon JP, Dujon A, Pujol JL, Brichon PY, Brouchet L, Quoix E, Westeel V, Le Chevalier T. Survival of patients with resected N2 non-small-cell lung cancer: evidence for a subclassification and implications. J Clin Oncol. 2000;18:2981–2989. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical